“Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial (LIBERTY AD ADOL)”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s51. https://doi.org/10.25251/skin.4.supp.50.